Neil S. Belloff
CIK 1741670 · General Counsel and Corp Secy · last filed 2023-04-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$442.1K
Companies
2
Total Filings
17
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acorda Therapeutics, Inc. (ACOR) Delisted | General Counsel and Corp Secy | — | $0.66 | — | $0 | 2 | 2023-04-04 |
| ELOX | COO, GENERAL COUNSEL &CORP SEC | 32,699 | $13.52 | $442.1K | $0 | 15 | 2021-07-30 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-01 | ELOX | Mixed | +1,103 | -$1.3K | EDGAR |
| 2020-03-04 | ELOX | Mixed | +4,084 | -$8.5K | EDGAR |
| 2020-02-26 | ELOX | Grant (A) | — | $0 | EDGAR |
| 2020-01-31 | ELOX | Mixed | +4,084 | -$8.5K | EDGAR |
| 2019-09-13 | ELOX | Grant (A) | — | $0 | EDGAR |
| 2019-01-31 | ELOX | Grant (A) | — | $0 | EDGAR |
| 2018-06-20 | ELOX | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.